
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.80 | 0.96 | 0.16 |
Stocks | 99.20 | 99.20 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.82 | 25.37 |
Price to Book | 7.30 | 5.50 |
Price to Sales | 7.04 | 4.78 |
Price to Cash Flow | 14.02 | 16.05 |
Dividend Yield | 0.49 | 0.84 |
5 Years Earnings Growth | 14.36 | 13.91 |
Name | Net % | Category Average |
---|---|---|
Technology | 72.36 | 64.36 |
Communication Services | 15.05 | 14.10 |
Consumer Cyclical | 9.14 | 9.24 |
Healthcare | 1.80 | 4.82 |
Real Estate | 1.65 | 1.70 |
Number of long holdings: 50
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alphabet C | US02079K1079 | 6.71 | 172.79 | +1.68% | |
Broadcom | US11135F1012 | 5.91 | 188.26 | -1.56% | |
NVIDIA | US67066G1040 | 5.81 | 120.69 | -0.59% | |
Apple | US0378331005 | 5.38 | 223.75 | +1.37% | |
Taiwan Semicon | TW0002330008 | 5.38 | 972.00 | 0.00% | |
Meta Platforms | US30303M1027 | 4.71 | 626.31 | +1.21% | |
Microsoft | US5949181045 | 4.20 | 395.16 | +0.53% | |
Amazon.com | US0231351067 | 4.18 | 205.71 | +1.21% | |
Salesforce Inc | US79466L3024 | 3.82 | 288.61 | +0.93% | |
ServiceNow Inc | US81762P1021 | 3.67 | 861.38 | +1.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology F | 1.1B | -4.99 | 7.63 | 17.40 | ||
GB00B5LXGG05 | 1.06B | -3.24 | 12.67 | 15.55 | ||
AXA Framlington Health Fund Z GBP A | 540.88M | 4.06 | 7.12 | 8.02 | ||
AXA Global Distribution R Acc | 255.12M | 5.74 | -1.26 | 4.97 | ||
AXA Global Distribution R Inc | 255.12M | 7.05 | -0.84 | 5.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review